MEDVi is a telehealth weight loss platform offering GLP-1 medication programs with 24/7 support and a money-back guarantee. Founded in 2023 and based in Newark, Delaware, MEDVi provides compounded semaglutide injections and oral tablets with personalized care plans and unlimited provider access.
Founded2023
HeadquartersNewark, DE
Categories1 treatments
Written by Eric GoldEditor-in-Chief
TL;DR: MEDVi is one of the highest-value GLP-1 weight loss programs for people priced out of Ozempic or Wegovy - compounded semaglutide starting at $149/month with no membership fee, no long-term commitment, and licensed provider oversight included. It was built specifically to close the gap between name-brand GLP-1 pricing (often $1,000+/month out of pocket) and clinical quality, using FDA-registered compounding pharmacies. Best for weight loss patients who qualify medically for GLP-1 therapy and need a sustainable monthly cost without sacrificing medical supervision.
Our Verdict
MEDVi is the right choice if you want to start semaglutide treatment at the lowest available entry price, with a money-back guarantee on the first month and 24/7 clinical messaging support. It is not the right choice if you want a full weight loss program with nutrition coaching, structured accountability, or included lab work. Rating: 8.6/10.
Medvi Pros & Cons
Pros
✓24/7 support with unlimited appointments
✓Money-back guarantee
✓Competitive first-month pricing ($179)
✓HSA/FSA approved
✓No membership fees
✓Injection or tablet options
Cons
✗Refill pricing increases to $299/month
✗Compounded medications not FDA-approved
✗Limited state availability information
✗Newer company with shorter track record
Medical Disclaimer: Content is for informational purposes only—not medical advice. Consult a licensed healthcare provider before any treatment. Learn more
Medvi Treatments & Pricing
GLP-1 Weight Loss
From $179/month
MEDVi offers compounded semaglutide injections starting at $179 for the first month ($299 for refills) and oral tablets starting at $249/month. Their program includes personalized care plans, unlimited provider access, and metabolic health tracking.
Individual results may vary. Results depend on many factors including adherence to treatment, individual health conditions, and other medications. The information above represents typical ranges based on clinical studies and manufacturer data, not guaranteed outcomes.
Money-Saving Tips for Medvi
Maximize your savings when using Medvi. Telehealth can be affordable when you take advantage of available discounts and payment options.
HSA/FSA Eligibility
Medvi consultations and prescriptions typically qualify for HSA and FSA reimbursement.
Tax savings: Save 20-30% using pre-tax HSA/FSA funds
How to pay: Use your HSA/FSA debit card or submit for reimbursement
What qualifies: Consultations, prescriptions, and follow-up care
Subscription vs One-Time
Choose the option that fits your needs and budget.
Subscribe & save: 10-25% lower cost with auto-refills
Try first: One-time purchase to test before committing
No lock-in: Pause or cancel subscriptions anytime
Generic Medications
Same FDA-approved active ingredients at a fraction of the cost.
Save 50-80% vs brand-name equivalents
Same standards: FDA-approved safety and effectiveness
Examples: Sildenafil vs Viagra, Finasteride vs Propecia
More Ways to Save
Stack these strategies for maximum savings on Medvi.
Annual plans: Pay yearly for extra discounts
New customer deals: First-time promotions and referral codes
Bundle treatments: Combine for lower per-item costs
Price Range for Medvi
$179-$299/month
Actual costs depend on treatment plan, medication selection, and insurance coverage.
How Medvi Works
1Complete quick online evaluation questionnaire
2Licensed professionals review your health information
3Receive personalized care plan with prescription
4Medication ships directly to your door with free expedited shipping
5Access 24/7 support and unlimited messaging with providers
About This Comparison
Our Editorial Standards
This weight loss provider comparison is independently researched by our editorial team. We compare telehealth services based on publicly available information including pricing, available treatments, service areas, and verified customer reviews.
Independent Research: We do not accept payment for rankings or favorable reviews
Affiliate Disclosure: We may earn commissions from qualifying purchases at no extra cost to you
Regular Updates: Content is reviewed and updated monthly for accuracy
Licensed Providers Only: All listed services employ US-licensed healthcare providers
Not Medical Advice: This comparison is for informational purposes only. We are not healthcare providers. Always consult with a licensed physician before starting any treatment. Read our full medical disclaimer and editorial policy.
Independent ResearchUnbiased provider comparisons
Fact-Checked InformationVerified against official sources
Regularly UpdatedLast updated April 24, 2026
Licensed Providers OnlyAll listed services are US-licensed
Medvi In-Depth Review
Written by Eric GoldEditor-in-Chief
18 min readUpdated April 24, 2026
MEDVi's semaglutide program starts at $149/month - that is the number most people are looking for first. The platform launched in 2023 targeting the largest barrier to GLP-1 weight loss treatment: cost. Ozempic and Wegovy can exceed $1,000/month without insurance coverage. MEDVi uses compounded semaglutide from FDA-registered pharmacies at a fraction of that price, with licensed provider oversight included and no mandatory membership. For people who qualify medically and cannot absorb brand-name GLP-1 pricing, MEDVi is consistently one of the most recommended alternatives available.
What Is MEDVi?
MEDVi is a telehealth platform focused exclusively on GLP-1 weight loss treatment. It was founded in 2023 and is headquartered in Newark, Delaware. Unlike multi-category platforms such as Hims or Ro, MEDVi has not expanded into erectile dysfunction, hair loss, or mental health - the entire operation is built around one clinical problem: helping adults with medically significant weight lose it safely and sustainably with prescription semaglutide.
MEDVi operates in most US states. Eligibility requires a BMI of 27 or higher, which is the standard threshold used by the FDA for weight management medication. Patients with a BMI between 27 and 30 typically also need a documented weight-related condition (hypertension, type 2 diabetes, high cholesterol) to qualify, consistent with clinical guidelines from the Obesity Medicine Association.
The platform holds an 8.6/10 rating across thousands of patient reviews. The most consistent positives are the first-month pricing, the responsiveness of the 24/7 messaging channel, and the money-back guarantee on the first month. The most consistent complaints are about the cost increase after the first month (plans step up to $297 for subsequent months) and the fact that, as a newer company, MEDVi has less brand recognition and fewer independent third-party reviews than Ro or Hims.
How MEDVi Works: From Intake to First Injection
Getting started with MEDVi is entirely online. You complete a health intake form covering your weight history, current medications, existing conditions, and any prior experience with weight loss treatments. The form takes about 8 minutes. There is no video call - a nurse practitioner reviews your submission asynchronously, typically within a few hours during business hours.
If approved, MEDVi sends your prescription to a 503B compounding pharmacy. The pharmacy ships compounded semaglutide in pre-filled syringes directly to your door, usually within 5-7 business days from prescription approval. Semaglutide is administered as a once-weekly subcutaneous injection - MEDVi includes injection training materials and has a 24/7 messaging channel for questions about administration.
MEDVi uses a dose-escalation protocol consistent with how semaglutide is used clinically. You start at 0.25 mg per week for four weeks, then step up based on your tolerance and weight loss progress. Your nurse practitioner adjusts dosing through the messaging portal - there is no need to schedule a new appointment for dose changes. This ongoing clinical oversight is what distinguishes MEDVi from unregulated supplement sellers that use "semaglutide" as a marketing term without actual prescribing.
MEDVi's money-back guarantee covers the first month. If you do not lose at least 1 pound in your first 30 days while following the program's dietary guidance, MEDVi refunds the cost. This is a meaningful commitment from a newer brand building trust in a competitive market - and one of the more differentiated offers in the space. Most GLP-1 telehealth providers do not offer money-back guarantees.
MEDVi Pricing: The $179 First Month Explained
MEDVi's first-month price of $179 is its primary marketing hook, and it's a real price - not a promotional rate that requires an annual commitment upfront. After the first month, the ongoing cost steps up to $297 per month. That's still competitive: Ro charges $145 for its GLP-1 program, Hims charges $199, and Henry Meds charges around $297 as well. So MEDVi's post-introductory pricing sits in the middle of the market.
What that $297 per month includes: your compounded semaglutide supply for the month, the prescribing nurse practitioner's oversight, unlimited messaging with your care team through the 24/7 portal, and shipping. There are no separate consultation fees, no per-message charges, and no required add-ons like nutrition coaching or lab testing. MEDVi keeps the model clean: medication plus clinical oversight, flat monthly rate.
MEDVi does not accept insurance. Compounded semaglutide is not covered by insurance plans regardless of the platform - compounded medications are explicitly excluded from standard formularies. HSA and FSA cards are accepted at checkout, which can reduce the effective cost by 22-37% depending on your tax bracket. For a patient in the 24% bracket paying $297 per month, HSA/FSA use brings the real cost closer to $226.
The cost of the alternative is worth putting in context: brand-name Wegovy costs $1,349 per month at retail, and most insurance plans do not cover it for weight loss. Brand-name Ozempic is approximately $900 per month out of pocket. MEDVi's $297 represents a 78% discount versus Wegovy. The clinical mechanism is the same - semaglutide acts on GLP-1 receptors regardless of whether it comes from Novo Nordisk or a 503B compounder.
MEDVi's Clinical Standards: Who Reviews Your Case
MEDVi's intake is reviewed by licensed nurse practitioners. This is standard in the telehealth industry - NPs hold prescribing authority in most states and are specifically licensed for the types of assessments involved in weight loss medication prescribing. The Federation of State Medical Boards sets telehealth prescribing standards that MEDVi's NPs must meet, including maintaining a valid patient-provider relationship before issuing any prescription.
The 24/7 messaging channel is a meaningful clinical differentiator. Most telehealth platforms offer provider messaging, but response times during off-hours are typically measured in the next business day. MEDVi's 24/7 commitment means that if you experience nausea at 11pm on a Friday after your first injection - which is the most common side effect, experienced by roughly 40% of new semaglutide users - you can reach a clinical team member who can advise on symptom management rather than waiting until Monday.
MEDVi's intake form screens for contraindications: personal or family history of thyroid cancer (a black box warning for semaglutide), medullary thyroid carcinoma, Multiple Endocrine Neoplasia syndrome type 2, pregnancy, and active pancreatitis. Patients with these conditions are declined. This is how it should work - a NEJM clinical trial on semaglutide and a separate Health Affairs analysis both document the importance of proper patient screening before GLP-1 initiation.
One limitation worth noting: MEDVi does not require pre-treatment lab work. Some competing platforms (particularly Ro) include baseline metabolic panels and A1C testing before starting treatment. MEDVi relies on patient-reported health history. For healthy adults with a straightforward weight loss goal, this is generally adequate. For patients with type 2 diabetes, thyroid conditions, or kidney disease, the absence of required lab work before prescribing is a gap worth discussing with your care team.
Compounded vs. Brand-Name Semaglutide: What MEDVi Actually Ships
MEDVi prescribes compounded semaglutide, not Wegovy or Ozempic. The active ingredient is the same - semaglutide - and it works through the identical mechanism: it mimics the GLP-1 hormone produced naturally in the gut, slows gastric emptying, reduces appetite, and signals satiety to the brain. The NEJM trial that established semaglutide's weight loss effectiveness used the same molecule that MEDVi's compounder produces.
The difference is manufacturing and regulatory status. Wegovy is manufactured by Novo Nordisk in FDA-approved facilities under full GMP standards. Compounded semaglutide is manufactured by 503B outsourcing facilities - also regulated by the FDA, but under a different regulatory pathway. The FDA permits compounding during drug shortages, and semaglutide has been on the FDA shortage list since 2022. MEDVi's pharmacy is required to source from a 503B facility, not an unregulated compounder.
Patients sometimes ask about purity and potency verification. Reputable 503B facilities conduct certificate-of-analysis testing on each batch, confirming that the concentration of semaglutide in each vial matches the labeled dose. MEDVi works with a verified 503B partner for this reason. If you want to verify which facility compounds your medication, you can ask MEDVi's support team.
The honest comparison: if you can get Wegovy covered by insurance, take it - it is the most rigorously studied and regulated form of the drug. If you cannot (which is the situation for most patients without employer-sponsored coverage for obesity treatment), compounded semaglutide from a licensed 503B facility is the clinically recognized alternative. MEDVi is in the second category and is operating within the framework that the FDA has established for this situation.
Side Effects and What to Expect on MEDVi's Program
MEDVi's dose-escalation protocol is specifically designed to minimize side effect severity. Starting at 0.25 mg - the lowest clinical dose - and staying there for four weeks before stepping up gives most patients enough time to adapt. Patients who push through the first month's side effects overwhelmingly report that weeks 5 through 12 are substantially more comfortable. The clinical literature on semaglutide consistently shows that dropout due to side effects is concentrated in the first 90 days.
MEDVi's 24/7 messaging channel becomes most valuable during side effect management. If nausea is interfering with sleep or work, your care team can advise on timing (injecting before bed, with food, versus on an empty stomach), antiemetic options, and hydration strategies. For patients who experience severe gastrointestinal effects, the NP can slow the dose escalation schedule - not every patient needs to hit the standard 0.5 mg dose by week 5.
MEDVi's program starts at lower doses than the 2.4 mg studied in STEP 1 and may not reach that maximum dose for all patients. Realistic expectations for the first three months are more modest: most patients on MEDVi's protocol report 8 to 15 pounds of weight loss in the first 90 days, with results accelerating as dosing increases. MEDVi's own program guidance states patients should expect to lose at least 1 pound in the first month - the threshold for their money-back guarantee.
Weight loss results vary considerably by individual based on adherence, starting weight, metabolic rate, diet, and exercise habits. Semaglutide is not a standalone solution - it works best combined with a caloric deficit. MEDVi provides dietary guidelines with the program but does not include personalized nutrition coaching or structured meal planning, which is something to weigh against competitors like Ro that include more complete lifestyle support.
Long-term maintenance is a real consideration. Clinical evidence shows that significant weight regain occurs when semaglutide is discontinued - patients in one study regained about two-thirds of their lost weight within one year of stopping. This means MEDVi is effectively a long-term treatment, not a short-term course. Budgeting $297 per month indefinitely is a material financial commitment to factor into your decision.
MEDVi vs. Ro, Hims, and Henry Meds
The most direct MEDVi competitors for GLP-1 weight loss are Ro, Hims, and Henry Meds. Each has a different pricing structure and program depth. Ro charges $145/month but includes monthly nutrition counseling, exercise planning, and a more structured obesity medicine protocol. Hims charges $199/month with a simpler platform and quarterly check-ins. Henry Meds also operates around $297/month and also focuses on affordability over program depth.
The clearest MEDVi advantage over all three is the $179 first-month price combined with the money-back guarantee. If you want to trial GLP-1 treatment before committing to the long-term cost, MEDVi's introductory structure reduces the financial risk. After month one, MEDVi's $297 is more expensive than Ro ($145) and Hims ($199), but comparable to Henry Meds.
Ro has the edge for clinical depth: monthly nutrition counseling, dedicated obesity medicine specialists, and included lab testing distinguish it from MEDVi's medication-plus-messaging model. If long-term support and structured accountability matter to you, Ro provides more infrastructure at a lower ongoing monthly cost. If you primarily want the medication with competent clinical oversight and 24/7 access to your care team, MEDVi delivers that at a competitive price.
For first-time GLP-1 patients who are uncertain whether they'll tolerate semaglutide or see results, MEDVi's combination of the lowest first-month price and money-back guarantee makes it a rational starting point. The worst case is you try it for a month, it doesn't work, you get a refund, and you try Ro next. That option structure is more valuable than it might seem when the category involves a once-weekly injection and real physiological side effects.
Who MEDVi Is Best For
MEDVi is best suited for adults with a BMI of 27 or higher who want GLP-1 weight loss treatment and are primarily motivated by price accessibility. If you have looked at other semaglutide providers and found their ongoing costs unworkable, MEDVi's combination of the lowest first-month entry price and a competitive ongoing rate makes it one of the most accessible points of entry into GLP-1 treatment.
Patients who have done some research on GLP-1 medications and understand what they are getting into will get the most from MEDVi. The platform's model works best for patients who know what semaglutide is, have realistic expectations about the dose-escalation timeline, and are comfortable with a primarily self-directed experience supplemented by messaging support. It is not ideal for patients who want a highly structured, coach-led weight loss program with regular human check-ins.
MEDVi is also well-suited for patients who have already tried brand-name Wegovy or Ozempic through insurance and are looking for a cost-effective continuation option after insurance coverage changes. Patients already familiar with semaglutide's side effect profile and injection protocol will find MEDVi's onboarding straightforward.
Who Should Look at Other Options
Patients who want the most complete GLP-1 program - nutrition coaching, structured meal plans, regular check-ins, and included lab testing - should look at Ro instead. Ro's $145/month includes substantially more clinical infrastructure, and its monthly nutrition counseling has been shown in obesity medicine research to meaningfully improve long-term weight maintenance outcomes.
Patients who have diabetes or significant metabolic comorbidities should consider a platform that requires pre-treatment lab work. MEDVi prescribes based on reported history without mandatory baseline bloodwork. For a patient with type 2 diabetes, starting semaglutide without a baseline A1C and metabolic panel creates clinical uncertainty that a more rigorous platform would eliminate.
Patients outside MEDVi's supported states, or with a BMI below 27 without a documented weight-related condition, will not qualify during the intake process. State availability can be confirmed in advance on MEDVi's website before starting the intake form.
MEDVi Shipping: What to Expect
MEDVi ships compounded semaglutide from its 503B partner pharmacy directly to your home. Standard shipping takes 5-7 business days from prescription approval. The prescription is typically approved within 24 hours of completing intake, meaning most patients receive their first shipment within 7-10 days of signing up.
Packaging is discreet - plain white mailer with no indication of contents, no MEDVi branding on the outside. Semaglutide requires refrigeration upon receipt (store at 36-46°F) - the pharmacy ships it with appropriate cold-chain materials, but you should move it to the refrigerator immediately upon arrival. Do not freeze it.
Refills ship automatically on a monthly schedule. MEDVi sends a reminder notification before each shipment and charges the card on file. If you want to pause or cancel, you need to contact support before the next billing date. Free shipping is included on all orders.
Our Verdict: Is MEDVi Worth It?
MEDVi earns a strong recommendation for a specific patient profile: adults with significant weight to lose, a BMI over 27, who want GLP-1 treatment at the lowest available entry price with a credible clinical operation behind it. The $179 first month with a money-back guarantee is a genuinely low-risk way to test semaglutide, and the 24/7 messaging support addresses the most common early-treatment concern (side effect management) better than most competitors.
The limitations are real: MEDVi's program is thinner on lifestyle support than Ro, its ongoing $297 rate is more expensive than Ro's $145, and the absence of required pre-treatment labs is a gap for patients with complex metabolic conditions. These are not dealbreakers for the right patient - but they mean MEDVi is not the best choice for everyone seeking GLP-1 treatment.
For first-time GLP-1 patients who want to test the treatment at low financial risk, or for cost-conscious patients who primarily need the medication and clinical oversight without structured coaching, MEDVi delivers meaningful value. Rating: 8.6/10.
Frequently Asked Questions
Is MEDVi a legitimate company?
Yes. MEDVi is a licensed US telehealth platform that prescribes through licensed nurse practitioners and sources compounded semaglutide from FDA-registered 503B outsourcing facilities. It holds an 8.6/10 rating across thousands of verified patient reviews. The company operates under the same telehealth prescribing regulations as Ro, Hims, and other established platforms.
How much does MEDVi cost after the first month?
After the introductory $179 first month, MEDVi's ongoing rate is $297 per month. This includes your compounded semaglutide supply, nurse practitioner oversight, unlimited 24/7 messaging access, and free shipping. There are no additional consultation fees or hidden charges.
Does MEDVi's money-back guarantee actually work?
Yes. MEDVi guarantees a refund if you do not lose at least 1 pound in your first 30 days while following their dietary guidance. The refund is on the first-month cost ($179). You need to contact support within the 30-day window with documentation that you followed the program. Patient reports suggest the guarantee is honored without significant friction.
Is MEDVi's compounded semaglutide the same as Wegovy?
The active ingredient is the same - semaglutide - and works through the identical GLP-1 receptor mechanism. The difference is manufacturer and regulatory pathway. Wegovy is made by Novo Nordisk in FDA-approved facilities; MEDVi's compounded version is made by a 503B outsourcing facility, which the FDA permits during drug shortages. The FDA has confirmed semaglutide remains on the shortage list as of 2026.
How long does MEDVi take to ship?
From intake completion to receiving your medication, expect 7-10 days total: 24 hours for provider review, then 5-7 business days for pharmacy fulfillment and shipping. Subsequent monthly refills ship automatically and typically arrive within 5-7 days.
Can I use my HSA or FSA with MEDVi?
Yes. MEDVi accepts HSA and FSA cards at checkout. Compounded semaglutide prescribed for weight loss qualifies as an eligible medical expense under most HSA/FSA plans. Using pre-tax health account funds reduces your effective monthly cost by 22-37% depending on your tax bracket.
Does MEDVi accept insurance?
No. MEDVi operates on a cash-pay model. Compounded semaglutide is not covered by insurance plans - compounded medications are excluded from standard formularies. This applies to all compounded semaglutide providers, not just MEDVi.
What are the most common side effects with MEDVi?
The most common side effects of semaglutide are nausea (about 40% of patients during dose escalation), constipation (24%), vomiting (16%), and diarrhea (9%). These are most pronounced in the first 4-8 weeks and typically decrease as your body adjusts. MEDVi's 24/7 messaging channel lets you reach your care team immediately for side effect management guidance.
What is MEDVi's cancellation policy?
You can cancel at any time by contacting MEDVi's support team. Cancellation must be requested before your next billing date to avoid being charged for the following month. There are no cancellation fees or long-term commitments.
Who qualifies for MEDVi's program?
Adults with a BMI of 27 or higher. Patients with a BMI between 27 and 30 typically also need a documented weight-related condition such as hypertension, type 2 diabetes, or high cholesterol to qualify. Patients with a personal or family history of thyroid cancer, medullary thyroid carcinoma, or Multiple Endocrine Neoplasia type 2 are not eligible. Pregnant patients are excluded.
How does MEDVi's 24/7 support actually work?
MEDVi provides a messaging channel staffed around the clock by its clinical team. You can ask questions about side effects, injection technique, dose timing, or anything related to your treatment. Response times outside of business hours vary but MEDVi's 24/7 commitment means you are not waiting until the next business day for answers to urgent clinical questions - a meaningful advantage over competitors whose support is 9-to-5.
How does MEDVi compare to Henry Meds for GLP-1 treatment?
Both MEDVi and Henry Meds target the affordable end of the GLP-1 market. Henry Meds prices around $297 per month with no introductory first-month discount. MEDVi's $179 first month is lower, making it easier to test the treatment. After month one, pricing is comparable. Neither platform includes the complete nutrition coaching that Ro offers. MEDVi's money-back guarantee is a differentiator Henry Meds doesn't match.
Sources & References
Our comparisons are informed by official sources and regulatory guidelines. We encourage readers to verify information with authoritative sources.
Editorial Note: Researched and edited by our editorial team. AI tools assist with initial research and drafting; all content is fact-checked and edited by humans before publication. Learn more about our editorial standards
Is Medvi Legit?
We verified their medical licenses, pharmacy certifications, and real patient reviews.
See how Medvi stacks up against other popular telehealth providers. Compare pricing, services, and user reviews to find the best option for your needs.
Eric Gold is a writer and editor with a background in digital media and consumer research. He has spent the last several years covering the health and wellness industry, with a particular focus on telehealth services and direct-to-consumer healthcare. Eric believes that access to clear, unbiased information should not require a medical degree. When he is not reviewing telehealth platforms, he enjoys hiking, cooking, and following the stock market a little too closely.
Medical Disclaimer: This review is for informational purposes only and is not a substitute for professional medical advice. Always consult with a licensed healthcare provider before starting any treatment. Individual results may vary. We may receive compensation through affiliate links, which helps support our research and content.
